发明申请
- 专利标题: Use of Mrf-2 for screening and therapies
- 专利标题(中): 使用Mrf-2进行筛选和治疗
-
申请号: US11140510申请日: 2005-05-25
-
公开(公告)号: US20060014178A1公开(公告)日: 2006-01-19
- 发明人: Robert Whitson , Keiichi Itakura
- 申请人: Robert Whitson , Keiichi Itakura
- 主分类号: C12Q1/68
- IPC分类号: C12Q1/68 ; C12P19/34
摘要:
Mrf-2 is essential for accumulation of lipid stores in postnatal life. Homozygous loss of the ARID gene Mrf-2 resulted in a high rate of neonatal mortality that was partially strain-dependent in mice. Loss of Mrf-2 expression did not affect embryonic survival, embryonic growth or birth weight. Lipid accumulation was severely reduced in brown adipose of Mrf-2−/− neonates at 24 hours of age, however, and Mrf-2−/− mice weighed significantly less than controls from postnatal day five onward. Adult Mrf-2−/− mice were lean, with significant reductions in brown and white adipose tissues, and in the percentage of body fat. Mrf-2−/− and Mrf-2± mice were also resistant to weight gains and obesity when maintained on high fat diets.
信息查询